Institute of Tropical Medicine, Belgium: Leishmaniasis trials

The registry lists 12 Leishmaniasis studies with Institute of Tropical Medicine, Belgium as lead sponsor. 4 are open to participants now and 1 have results posted.

Phase 3 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Ex Vivo Immunogenicity Screening of Vaccine Candidate Antigen Combinations in Ethiopian Patients With LeishmaniasisRecruitingNCT07783243
• Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in EthiopiaNot yet recruitingNCT06695143Phase 3
• OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis PatientsRecruitingNCT06514560
• Clinical Prognostic Score to Predict Relapse in VLRecruitingNCT05602610
• Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort StudyCompletedNCT01360762Phase 3Results posted
• Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in EthiopiaCompletedNCT05332093
• Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in EthiopiaCompletedNCT04699383
• Outcomes of Complicated CL in Ethiopia Treated With MiltefosineCompletedNCT04004754
• Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in BelgiumTerminatedNCT04001335
• Cutaneous Leishmaniasis Diagnostic StudyCompletedNCT03837431
• Predicting Visceral Leishmaniasis in HIV Infected PatientsTerminatedNCT03013673
• Asymptomatic Leishmania Infection in HIV PatientsTerminatedNCT02839603